Tucson, AZ, United States of America

Imarx Therapeutics, Inc.

Calculating rank
USPTO Granted Patents = 14

% Expired Patents = 28.6

Forward Citations = 958

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Evan C Unger (14 out of 134 patents)

silverMedal Yunqiu Wu (3 out of 7 patents)

bronzeMedal Thomas McCreery (3 out of 8 patents)

4.  DeKang Shen (2 out of 10 patents)

5.  Patricia A Schumann (1 out of 1 patent)

6.  Guanli Wu (1 out of 30 patents)

7.  Terry Onichi Matsunaga (1 out of 25 patents)


14 patents:

Company Overview
Imarx Therapeutics, Inc. is a biotechnology company based in Tucson, Arizona, focused on developing innovative therapeutic solutions. The company specializes in advanced drug delivery systems and targeted therapies, aiming to enhance treatment efficacy and patient outcomes. With a commitment to addressing unmet medical needs, Imarx leverages cutting-edge research and technology to create novel approaches in the fields of oncology and other critical health areas. Their work emphasizes precision medicine and the integration of scientific advancements into practical healthcare solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

14 Patents

#45 in Tucson, AZ

#277 in Arizona

#22,350 in US

#42,333 in the World

Tucson, AZ (US)
Tucson, AZ, United States of America
Forward Citations = 958

7 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Imarx Therapeutics, Inc.. Retrieved from https://idiyas.com/company/imarx-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…